214 related articles for article (PubMed ID: 26062958)
21. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.
Myers RP; Pomier-Layrargues G; Kirsch R; Pollett A; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
J Hepatol; 2012 Mar; 56(3):564-70. PubMed ID: 22027584
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.
Nabi O; Lacombe K; Boursier J; Mathurin P; Zins M; Serfaty L
Gastroenterology; 2020 Aug; 159(2):791-793.e2. PubMed ID: 32376412
[No Abstract] [Full Text] [Related]
23. High Dietary Sodium Intake Assessed by Estimated 24-h Urinary Sodium Excretion Is Associated with NAFLD and Hepatic Fibrosis.
Huh JH; Lee KJ; Lim JS; Lee MY; Park HJ; Kim MY; Kim JW; Chung CH; Shin JY; Kim HS; Kwon SO; Baik SK
PLoS One; 2015; 10(11):e0143222. PubMed ID: 26571018
[TBL] [Abstract][Full Text] [Related]
24. Previously unrecognized advanced liver disease unveiled by transient elastography in patients with Haemophilia and chronic hepatitis C.
Moessner BK; Andersen ES; Weis N; Laursen AL; Ingerslev J; Lethagen S; Pedersen C; Christensen PB
Haemophilia; 2011 Nov; 17(6):938-43. PubMed ID: 21435119
[TBL] [Abstract][Full Text] [Related]
25. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease.
Sinn DH; Gwak GY; Cho J; Son HJ; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Atherosclerosis; 2014 Jun; 234(2):270-5. PubMed ID: 24704629
[TBL] [Abstract][Full Text] [Related]
26. Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease.
Mahadeva S; Mahfudz AS; Vijayanathan A; Goh KL; Kulenthran A; Cheah PL
J Dig Dis; 2013 Nov; 14(11):604-10. PubMed ID: 23859493
[TBL] [Abstract][Full Text] [Related]
27. Outreach screening of drug users for cirrhosis with transient elastography.
Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
[TBL] [Abstract][Full Text] [Related]
28. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
[TBL] [Abstract][Full Text] [Related]
29. A Comparison of Brunt's Criteria, the Non-Alcoholic Fatty Liver Disease Activity Score (NAS), and a Proposed NAS Scoring that Includes Fibrosis in Non-Alcoholic Fatty Liver Disease Staging.
Santiago-Rolón A; Purcell D; Rosado K; Toro DH
P R Health Sci J; 2015 Dec; 34(4):189-94. PubMed ID: 26602577
[TBL] [Abstract][Full Text] [Related]
30. A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease.
Aykut UE; Akyuz U; Yesil A; Eren F; Gerin F; Ergelen R; Celikel CA; Yilmaz Y
Scand J Gastroenterol; 2014 Nov; 49(11):1343-8. PubMed ID: 25259621
[TBL] [Abstract][Full Text] [Related]
31. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
[TBL] [Abstract][Full Text] [Related]
32. Psoriasis and liver fibrosis: an investigation using transient elastography in Tunisian patients with psoriasis.
Ben Lagha I; Jaber K; Rabhi F; Slimane BB; Mrabet A; Abdelli N; Dhaoui MR
Br J Dermatol; 2019 Dec; 181(6):1306-1308. PubMed ID: 31145808
[No Abstract] [Full Text] [Related]
33. A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease.
Casey SP; Kemp WW; McLean CA; Topliss DJ; Adams LA; Roberts SK
Scand J Gastroenterol; 2012 Jul; 47(7):836-41. PubMed ID: 22519948
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of non-alcoholic fatty liver and liver fibrosis in patients with moderate-severe psoriasis: A cross-sectional cohort study.
Magdaleno-Tapial J; Valenzuela-Oñate C; Ortiz-Salvador JM; Martínez-Doménech Á; García-Legaz-Martínez M; Alonso-Carpio M; Tamarit-García JJ; Diago-Madrid M; Sánchez-Carazo JL; Pérez-Ferriols A
Australas J Dermatol; 2020 May; 61(2):105-109. PubMed ID: 31731325
[TBL] [Abstract][Full Text] [Related]
35. Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis.
Kim TY; Kim JY; Sohn JH; Lee HS; Bang SY; Kim Y; Kim MY; Jeong WK
J Ultrasound Med; 2015 Sep; 34(9):1621-30. PubMed ID: 26269292
[TBL] [Abstract][Full Text] [Related]
36. [Using transient elastography as a screening tool for liver fibrosis in addiction service].
Lahmek P; Meunier N; Michel L; Aubin HJ; Balester-Mouret S
Presse Med; 2014 Mar; 43(3):e17-31. PubMed ID: 24485827
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.
Wong VW; Vergniol J; Wong GL; Foucher J; Chan HL; Le Bail B; Choi PC; Kowo M; Chan AW; Merrouche W; Sung JJ; de Lédinghen V
Hepatology; 2010 Feb; 51(2):454-62. PubMed ID: 20101745
[TBL] [Abstract][Full Text] [Related]
38. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.
Friedrich-Rust M; Koch C; Rentzsch A; Sarrazin C; Schwarz P; Herrmann E; Lindinger A; Sarrazin U; Poynard T; Schäfers HJ; Zeuzem S; Abdul-Khaliq H
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):560-7. PubMed ID: 18329470
[TBL] [Abstract][Full Text] [Related]
39. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.
Wong VW; Wong GL; Yeung DK; Lau TK; Chan CK; Chim AM; Abrigo JM; Chan RS; Woo J; Tse YK; Chu WC; Chan HL
J Hepatol; 2015 Jan; 62(1):182-9. PubMed ID: 25195550
[TBL] [Abstract][Full Text] [Related]
40. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease.
Krawczyk M; Grünhage F; Zimmer V; Lammert F
J Hepatol; 2011 Aug; 55(2):299-306. PubMed ID: 21168459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
